|
A Phase II Open-Label Study of Ganetespib, a Novel Heat Shock Protein 90 Inhibitor for Patients With Metastatic Breast Cancer |
|
|
|
Title: |
A Phase II Open-Label Study of Ganetespib, a Novel Heat Shock Protein 90 Inhibitor for Patients With Metastatic Breast Cancer |
Author: |
Jhaveri, Komal Chandarlapaty, Sarat Lake, Diana Gilewski, Teresa Robson, Mark Goldfarb, Shari Drullinsky, Pamela Sugarman, Steven Wasserheit-Leiblich, Carolyn Fasano, Julie Moynahan, Mary Ellen D'Andrea, Gabriella Lim, Kristina Reddington, Laura Haque, Sofia Patil, Sujata Bauman, Lynne Vukovic, Vojo El-Hariry, Iman Hudis, Clifford Modi, Shanu |
Appeared in: |
Clinical breast cancer |
Paging: |
Volume 14 (2014) nr. 3 pages 7 p. |
Year: |
2014 |
Contents: |
|
Publisher: |
Elsevier Inc. |
Source file: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|